HSP90AA1 and osteosarcoma: Further study demonstrated that AHA1 could positively affect the growth and metastasis of osteosarcoma cells both in vivo and in vitro, indicating that AHA1 might be a novel oncogene in osteosarcoma, which is consistent with the previous studies of Hsp90 inhibitors in osteosarcoma.